Zenith Capital Corporation

Equities

ZENI.P

CA98936P1071

Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 08:30:00 16/04/2024 pm IST			5-day change	1st Jan Change
0.105 ^CAD	-.--%		-.--%	-.--%

28/03	Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
2023	Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2023	CI

Zenith Capital Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2020

June 09, 2020 at 03:44 am IST

Zenith Capital Corporation announced earnings results for the third quarter ended April 30, 2020. For the third quarter, the company announced net loss was CAD 78,569 compared to CAD 102,256 a year ago. For the nine months, net loss was CAD 94,953 compared to CAD 102,256 a year ago.

Latest news about Zenith Capital Corporation

Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	28/03	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2023	28/11	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	14/23/14	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	28/23/28	CI
Grand Samsara Consulting LLC and CBGB Ventures Corp. signed a binding letter agreement to acquire Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction.	20/23/20	CI
Zenith Capital Corporation announced that it expects to receive CAD 1 million in funding from Grand Samsara Consulting LLC	08/23/08	CI
Zenith Capital Corporation announced that it has received CAD 0.2 million in funding	23/23/23	CI
Zenith Capital Corporation announced that it expects to receive CAD 0.2 million in funding	15/23/15	CI
Venda Robotix Ltd cancelled the acquisition of Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction..	23/23/23	CI
Zenith Capital Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022	09/22/09	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2022	17/22/17	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	22/22/22	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	29/22/29	CI
Zenith Capital Corporation Reports Earnings Results for the First Quarter Ended October 31, 2021	30/21/30	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2021	09/21/09	CI
Zenith Capital Corporation Auditor Raises 'Going Concern' Doubt	08/21/08	CI
Venda Robotix Ltd entered into a binding letter of intent to acquire Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction.	18/21/18	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2021	03/21/03	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter Ended January 31, 2021	06/21/06	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2020	16/20/16	CI
Zenith Capital Corporation Auditor Raises 'Going Concern' Doubt	15/20/15	CI
Zenith Capital Corporation announced that it has received $2.000001 million in funding	16/20/16	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2020	09/20/09	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter Ended January 31, 2020	10/20/10	CI
Zenith Capital Corporation has completed an IPO in the amount of CAD 0.2 million.	06/20/06	CI

Chart Zenith Capital Corporation

Duration

Period

More charts

Company Profile

Zenith Capital Corporation is a Canada-based capital pool company. The principal activity of the Company is the identification and evaluation of assets or a business and, once identified or evaluated, to negotiate an acquisition of, or participation in, a business subject to receipt of shareholders approval, if required, and acceptance by regulatory authorities (the Qualifying Transaction). The Company has not identified a business or asset that warrants acquisition or participation.

Sector

Biotechnology & Medical Research

Calendar

11/06/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ZENITH CAPITAL CORPORATION	-.--%	323K
MODERNA, INC.	+46.19%	55.7B
IQVIA HOLDINGS INC.	-6.14%	39.57B
LONZA GROUP AG	+40.06%	39.91B
CELLTRION, INC.	-6.65%	28.16B
ICON PUBLIC LIMITED COMPANY	+12.33%	26.3B
ALNYLAM PHARMACEUTICALS, INC.	-21.78%	18.94B
BIO-TECHNE CORPORATION	-0.35%	12.12B
UNITED THERAPEUTICS CORPORATION	+24.18%	12.12B
MEDPACE HOLDINGS, INC.	+28.38%	12.17B

Other Biotechnology & Medical Research